HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Samuel S Lee Selected Research

2'- fluoro- 2'- methyl- 3',5'- diisobutyryldeoxycytidine

1/2016Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Samuel S Lee Research Topics

Disease

32Fibrosis (Cirrhosis)
01/2022 - 02/2002
20Infections
10/2020 - 01/2004
17Cardiomyopathies (Cardiomyopathy)
01/2022 - 02/2002
16Chronic Hepatitis C
01/2022 - 10/2002
15Chronic Hepatitis B
12/2020 - 01/2006
7Heart Failure
01/2022 - 06/2006
7Hemorrhage
07/2021 - 03/2005
7Hepatitis C
01/2018 - 01/2004
5Liver Diseases (Liver Disease)
01/2019 - 07/2003
4Ascites
12/2021 - 02/2006
3End Stage Liver Disease
03/2022 - 01/2009
3Varicose Veins (Varicose Vein)
07/2021 - 03/2005
3Hepatorenal Syndrome
07/2020 - 02/2006
3Hepatocellular Carcinoma (Hepatoma)
01/2018 - 01/2009
3Heart Diseases (Heart Disease)
01/2018 - 06/2006
3Neoplasms (Cancer)
01/2014 - 09/2009
3Hepatitis B
07/2013 - 03/2006
3Necrosis
12/2012 - 02/2003
3Inflammation (Inflammations)
04/2011 - 12/2002
3Portal Hypertension
10/2007 - 02/2006
2Anemia
11/2021 - 11/2013
2Endotoxemia
07/2020 - 08/2010
2Liver Failure
01/2017 - 02/2006
2Autoimmune Hepatitis
01/2013 - 08/2005
2Chronic Hepatitis (Chronic Active Hepatitis)
06/2011 - 06/2007
2Cardiovascular Abnormalities
04/2011 - 02/2006
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2022
1Non-alcoholic Fatty Liver Disease
03/2022
1Cardiomegaly (Heart Hypertrophy)
01/2022
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2021
1Hemolytic Anemia
11/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1Acute-On-Chronic Liver Failure
05/2018
1HIV Infections (HIV Infection)
01/2018
1Virus Diseases (Viral Diseases)
01/2018

Drug/Important Bio-Agent (IBA)

12Antiviral Agents (Antivirals)IBA
01/2019 - 03/2003
11Ribavirin (Virazole)FDA LinkGeneric
11/2021 - 07/2011
8InterferonsIBA
01/2018 - 10/2002
7entecavirFDA Link
07/2013 - 03/2006
6Tenofovir (Viread)FDA Link
12/2020 - 01/2011
6peginterferon alfa-2a (Pegasys)FDA Link
01/2016 - 10/2002
5glecaprevir and pibrentasvirIBA
10/2020 - 10/2017
5EndocannabinoidsIBA
07/2020 - 10/2005
5NucleosidesIBA
05/2018 - 01/2006
5Pharmaceutical PreparationsIBA
10/2017 - 08/2006
5Hepatitis B e AntigensIBA
09/2012 - 01/2009
4Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2004
4Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2020 - 02/2002
4salicylhydroxamic acid (SHAM)IBA
06/2015 - 10/2005
3SodiumIBA
12/2021 - 02/2002
3Protein Isoforms (Isoforms)IBA
11/2020 - 02/2002
3pibrentasvirIBA
01/2019 - 10/2017
3glecaprevirIBA
01/2019 - 10/2017
3N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
01/2016 - 02/2013
3telaprevirIBA
01/2016 - 02/2013
3RNA (Ribonucleic Acid)IBA
01/2016 - 10/2002
3Protease Inhibitors (Protease Inhibitor)IBA
01/2016 - 02/2013
3Lamivudine (Epivir)FDA Link
09/2010 - 03/2006
2SofosbuvirIBA
01/2022 - 01/2018
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2021 - 02/2003
2Alanine Transaminase (SGPT)IBA
12/2021 - 01/2009
2CytokinesIBA
07/2020 - 05/2008
2DNA (Deoxyribonucleic Acid)IBA
03/2018 - 06/2007
2daclatasvirIBA
05/2015 - 02/2015
2Proteins (Proteins, Gene)FDA Link
01/2014 - 10/2005
2ErythropoietinFDA Link
11/2013 - 12/2012
2Rituximab (Mabthera)FDA Link
06/2013 - 01/2013
2Prednisone (Sone)FDA LinkGeneric
01/2013 - 08/2005
2Azathioprine (Imuran)FDA LinkGeneric
01/2013 - 08/2005
2NucleotidesIBA
01/2011 - 01/2006
2adefovir dipivoxil (Hepsera)FDA Link
01/2011 - 03/2006
2Nitric Oxide Synthase (NO Synthase)IBA
08/2008 - 02/2002
2TerlipressinIBA
08/2006 - 03/2005
2Interferon-alpha (Interferon Alfa)IBA
03/2006 - 01/2004
1Galectin 3 (LGALS3)IBA
01/2022
1AntibodiesIBA
01/2022
1Serum AlbuminIBA
12/2021
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
12/2021
1Glycophorins (Glycophorin C)IBA
11/2021
1Calcitriol Receptors (Calcitriol Receptor)IBA
11/2021
1Hemoglobins (Hemoglobin)IBA
11/2021
1Inosine TriphosphataseIBA
11/2021
1Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA
07/2021
1Myosins (Myosin)IBA
11/2020
1CalciumIBA
11/2020
1P-300IBA
10/2020
1Hepatitis B Surface Antigens (HBsAg)FDA Link
03/2018
1DobutamineFDA LinkGeneric
01/2018
1SimeprevirIBA
01/2018
1Metoprolol (Toprol-XL)FDA LinkGeneric
01/2018

Therapy/Procedure

27Therapeutics
03/2022 - 10/2002
18Liver Transplantation
03/2022 - 11/2005
6Ligation
11/2020 - 10/2005
4Surgical Portasystemic Shunt (Portosystemic Shunt)
08/2010 - 06/2006
3Stents
12/2011 - 01/2007
2Duration of Therapy
01/2018 - 02/2015
2Drug Therapy (Chemotherapy)
01/2014 - 09/2009
2Drug Tapering
11/2013 - 09/2012
2Intravenous Administration
07/2008 - 08/2006
1Aftercare (After-Treatment)
01/2018